A detailed history of Humankind Investments LLC transactions in Baxter International Inc stock. As of the latest transaction made, Humankind Investments LLC holds 32,726 shares of BAX stock, worth $1.12 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares
32,726
Previous 12,713 157.42%
Holding current value
$1.12 Million
Previous $543,000 101.47%
% of portfolio
0.3%
Previous 0.15%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$32.87 - $43.55 $657,827 - $871,566
20,013 Added 157.42%
32,726 $1.09 Million
Q1 2024

May 08, 2024

SELL
$37.88 - $43.77 $39,092 - $45,170
-1,032 Reduced 7.51%
12,713 $543,000
Q4 2023

Feb 14, 2024

BUY
$31.71 - $38.95 $64,022 - $78,640
2,019 Added 17.22%
13,745 $531,000
Q3 2023

Nov 13, 2023

BUY
$37.32 - $49.29 $8,247 - $10,893
221 Added 1.92%
11,726 $442,000
Q2 2023

Aug 09, 2023

BUY
$39.98 - $47.68 $138,730 - $165,449
3,470 Added 43.19%
11,505 $524,000
Q1 2023

Apr 25, 2023

BUY
$37.58 - $52.57 $78,091 - $109,240
2,078 Added 34.88%
8,035 $325,000
Q4 2022

Jan 26, 2023

BUY
$49.7 - $57.71 $30,068 - $34,914
605 Added 11.3%
5,957 $0
Q3 2022

Nov 09, 2022

BUY
$53.86 - $66.8 $87,037 - $107,948
1,616 Added 43.25%
5,352 $288,000
Q2 2022

Aug 05, 2022

SELL
$63.83 - $80.0 $112,021 - $140,400
-1,755 Reduced 31.96%
3,736 $240,000
Q1 2022

May 09, 2022

BUY
$76.85 - $89.45 $4,918 - $5,724
64 Added 1.18%
5,491 $426,000
Q4 2021

Mar 21, 2022

BUY
$74.57 - $87.19 $21,625 - $25,285
290 Added 5.65%
5,427 $466,000
Q3 2021

Mar 21, 2022

BUY
$73.77 - $83.61 $108,810 - $123,324
1,475 Added 40.28%
5,137 $413,000
Q2 2021

Mar 21, 2022

BUY
$80.5 - $88.01 $90,240 - $98,659
1,121 Added 44.12%
3,662 $295,000
Q1 2021

Mar 21, 2022

BUY
$76.38 - $86.03 $194,081 - $218,602
2,541 New
2,541 $214,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $17.3B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Humankind Investments LLC Portfolio

Follow Humankind Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Humankind Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Humankind Investments LLC with notifications on news.